We are live on
!
Find out more
Aberdeen Group Portfolio holdings
AUM
$71.2B
Turnover
9.3%
1-Year Est. Return
41.74%
This Fund
S&P 500
This Quarter
Est. Return
+15.18%
1 Year Est. Return
+41.74%
3 Year Est. Return
+120.47%
5 Year Est. Return
+149.18%
10 Year Est. Return
–
AUM
$46.2B
AUM Growth
+$4.02B
(+9.6%)
Cap. Flow
-$2.06B
Cap. Flow
% of AUM
-4.46%
Top 10 Holdings %
Top 10 Hldgs %
19.65%
Holding
934
New
52
Increased
488
Reduced
320
Closed
33
Avg Time Held
1.3
years
Top 10 Avg Time Held
1.2
years
Top 20 Avg Time Held
1.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$191M |
| 2 |
Microsoft
MSFT
|
+$169M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$162M |
| 4 |
Netflix
NFLX
|
+$126M |
| 5 |
Philip Morris
PM
|
+$87.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$231M |
| 2 |
Banco Bradesco
BBD
|
+$182M |
| 3 |
Amdocs
DOX
|
+$175M |
| 4 |
Oracle
ORCL
|
+$156M |
| 5 |
Chevron
CVX
|
+$145M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.31% |
| 2 | Technology | 14.86% |
| 3 | Consumer Discretionary | 13.47% |
| 4 | Healthcare | 10.93% |
| 5 | Communication Services | 10.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
601
Acuity Brands
AYI
$9.08B
| $5.77M | 0.01% |
48,044
+2,836
| +6% | +$353K |
2017 Q3
6 quarters
|
|
602
Xylem
XYL
$24.3B
| $5.71M | 0.01% |
72,227
+25,539
| +55% | +$1.86M |
2017 Q3
6 quarters
|
|
603
Teleflex
TFX
$5.53B
| $5.64M | 0.01% |
18,656
+16,070
| +621% | +$4.48M |
2018 Q2
3 quarters
|
|
|
CHN
604
DELISTED
China Fund
CHN
| $5.57M | 0.01% |
273,263
-187,636
| -41% | -$3.58M |
2017 Q3
6 quarters
|
|
|
INXN
605
DELISTED
Interxion Holding N.V.
INXN
| $5.56M | 0.01% |
83,377
-3,811
| -4% | -$236K |
2018 Q2
3 quarters
|
|
606
Clearway Energy Class C
CWEN
$3.63B
| $5.56M | 0.01% |
368,000
-20,200
| -5% | -$303K |
2018 Q4
1 quarter
|
|
607
Henry Schein
HSIC
$9.63B
| $5.54M | 0.01% |
92,085
+3,796
| +4% | +$229K |
2017 Q3
6 quarters
|
|
608
Equitable Holdings
EQH
$14.5B
| $5.53M | 0.01% |
274,298
+261,714
| +2,080% | +$5M |
2018 Q4
1 quarter
|
|
609
Universal Health Services
UHS
$10.9B
| $5.51M | 0.01% |
41,218
-55,750
| -57% | -$7.34M |
2017 Q3
6 quarters
|
|
|
ETFC
610
DELISTED
E*Trade Financial Corporation
ETFC
| $5.51M | 0.01% |
118,745
+35,113
| +42% | +$1.67M |
2017 Q3
6 quarters
|
|
611
Atmos Energy
ATO
$28.3B
| $5.51M | 0.01% |
53,503
+40,370
| +307% | +$3.93M |
2017 Q3
6 quarters
|
|
612
Blackstone Mortgage Trust
BXMT
$1.78B
| $5.5M | 0.01% |
158,984
| – | – |
2018 Q4
1 quarter
|
|
613
Gartner
IT
$13B
| $5.49M | 0.01% |
36,166
+12,545
| +53% | +$1.74M |
2017 Q3
6 quarters
|
|
614
Franklin Templeton
BEN
$15.7B
| $5.48M | 0.01% |
165,392
+43,576
| +36% | +$1.38M |
2017 Q3
6 quarters
|
|
615
Alliant Energy
LNT
$17.7B
| $5.47M | 0.01% |
115,981
+29,328
| +34% | +$1.31M |
2017 Q3
6 quarters
|
|
616
PG&E
PCG
$39.3B
| $5.45M | 0.01% |
306,044
-158,976
| -34% | -$2.57M |
2017 Q3
6 quarters
|
|
617
Sabre
SABR
$678M
| $5.42M | 0.01% |
253,169
+31,033
| +14% | +$689K |
2018 Q2
3 quarters
|
|
618
Hormel Foods
HRL
$11.2B
| $5.42M | 0.01% |
121,001
+35,044
| +41% | +$1.5M |
2017 Q3
6 quarters
|
|
619
Howmet Aerospace
HWM
$88.1B
| $5.4M | 0.01% |
368,533
+79,143
| +27% | +$1.13M |
2017 Q3
6 quarters
|
|
620
DELISTED
Nordstrom
JWN
| $5.33M | 0.01% |
120,074
+19,337
| +19% | +$882K |
2017 Q3
6 quarters
|
|
621
The Mosaic Company
MOS
$5.98B
| $5.28M | 0.01% |
193,275
+16,535
| +9% | +$504K |
2017 Q3
6 quarters
|
|
622
United Therapeutics
UTHR
$22.9B
| $5.25M | 0.01% |
44,730
| – | – |
2017 Q3
6 quarters
|
|
623
Packaging Corp of America
PKG
$21B
| $5.24M | 0.01% |
52,699
+28,093
| +114% | +$2.67M |
2017 Q3
6 quarters
|
|
624
NiSource
NI
$20.5B
| $5.2M | 0.01% |
181,279
+46,788
| +35% | +$1.26M |
2017 Q3
6 quarters
|
|
625
Dentsply Sirona
XRAY
$1.71B
| $5.18M | 0.01% |
104,551
+30,039
| +40% | +$1.32M |
2017 Q3
6 quarters
|
|
Similar funds
Aberdeen Group's Q1 2019 Portfolio in Review
As of Q1 2019, Aberdeen Group held 934 positions worth $46.2B, up 9.6% from $42.1B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Aberdeen Group withdrew a net $2.06B in Q1 2019, closing 33 positions and reducing 320 holdings. Its most notable exit was Twenty-First Century Fox, Inc. Class A, an estimated $36M position sold in full.
By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Aberdeen Group opened a new position in Linde worth $203M.
- Aberdeen Group's largest Q1 2019 buy was Linde: 1,152,668 shares worth $203M.
- Aberdeen Group added most to Microsoft in Q1 2019, an estimated $169M increase.
- Aberdeen Group's biggest Q1 2019 reduction was Pfizer, cutting an estimated $231M.
- Aberdeen Group fully exited Twenty-First Century Fox, Inc. Class A in Q1 2019, selling an estimated $36M.
- Aberdeen Group's ten largest holdings make up 20% of its $46.2B portfolio in Q1 2019.
- Aberdeen Group opened 52 new positions and closed 33 in Q1 2019.
- Aberdeen Group's portfolio value rose 9.6% quarter-over-quarter to $46.2B.
Based on Aberdeen Group's 13F filing for Q1 2019, filed 14 May 2019.